Sino Biopharmaceutical financials at a glance

+ Portfolio

The revenue of Sino Biopharmaceutical is reported as 26.19941 billion Dollars in the fiscal year 2023. The earnings were 0.13 Dollars per share in 2023, which was 8.33 higher than 2022. And about 5.04851 billion Dollars are reported as free cash flow in the financials of Sino Biopharmaceutical 2023. Dividends of 0.06 Dollars per share were paid to shareholders of Sino Biopharmaceutical stock SEHK:1177 in fiscal 2023.

HK$26.20B

Revenue

HK$0.13

Earnings Per Share

80.95%

Gross Margin %

HK$4.79B

Free Cash Flow

Revenue

26,199.41

Earnings Per Share

0.13

Gross Margin %

80.95

Free Cash Flow

4,794.54

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Rev.	Revenue	N/A	HK$26.20B	HK$28.78B	HK$26.86B	HK$23.65B	HK$24.23B	HK$20.89B	HK$14.82B	HK$14.09B	HK$12.15B	HK$9.92B	HK$7.92B	HK$6.67B	HK$4.69B	HK$3.44B	HK$2.85B	HK$2.01B	HK$1.05B	HK$726.99M	HK$780.76M	HK$1.11B
GM %	Gross Margin %	78.89%	80.95%	79.86%	80.15%	78.08%	79.67%	79.91%	79.14%	79.20%	77.67%	76.41%	77.49%	78.52%	78.50%	80.79%	80.23%	79.26%	82.33%	81.11%	81.56%	79.95%
OM	Operating Margin	20.25%	20.76%	20.43%	15.74%	17.33%	20.00%	19.73%	21.74%	20.00%	19.29%	17.89%	17.29%	18.05%	15.67%	20.84%	22.86%	22.54%	21.16%	15.67%	20.23%	21.45%
EPS	Earnings Per Share	HK$0.10	HK$0.13	HK$0.12	HK$0.73	HK$0.17	HK$0.17	HK$0.15	HK$0.12	HK$0.11	HK$0.13	HK$0.07	HK$0.05	HK$0.04	HK$0.03	HK$0.03	HK$0.02	HK$0.02	HK$0.01	HK$0.01	HK$0.11	HK$0.02
Div.	Dividends	N/A	HK$0.06	HK$0.11	HK$0.06	HK$0.07	HK$0.05	HK$0.05	HK$0.03	HK$0.02	HK$0.01	HK$0.01	HK$0.01	HK$0.01	HK$0.02	HK$0.02	HK$0.01	HK$0.01	HK$0.01	HK$0.01	HK$0.00	HK$0.01
PR %	Payout Ratio %	0	46.15%	91.67%	8.22%	41.18%	29.41%	33.33%	25.00%	18.18%	7.69%	14.29%	20.00%	25.00%	66.67%	66.67%	50.00%	50.00%	100.00%	100.00%	0.00%	50.00%
Sha.	Shares	N/AM	18,347.12M	18,468.07M	18,698.76M	18,781.02M	18,810.96M	18,838.7M	16,677.43M	16,677.43M	16,677.43M	16,677.43M	16,677.43M	16,677.43M	16,677.43M	16,728.68M	15,281.79M	15,281.95M	15,281.95M	15,281.95M	15,281.95M	13,943.39M
OCF	Operating Cash Flow	N/A	HK$6.12B	HK$6.27B	HK$5.37B	HK$5.33B	HK$5.32B	HK$5.09B	HK$3.73B	HK$3.06B	HK$1.91B	HK$1.85B	HK$1.27B	HK$1.28B	HK$889.92M	HK$420.49M	HK$604.04M	HK$365.99M	HK$227.00M	HK$0.00M	HK$0.00M	HK$0.00M
FCF	Free Cash Flow	N/A	HK$4.79B	HK$4.51B	HK$3.81B	HK$3.74B	HK$3.18B	HK$3.40B	HK$2.67B	HK$2.25B	HK$1.25B	HK$1.33B	HK$865.20M	HK$957.98M	HK$657.41M	HK$58.78M	HK$263.65M	HK$174.93M	HK$153.55M	HK$0.00M	HK$0.00M	HK$0.00M
FCFS	Free Cash Flow Per Share	HK$0.18	HK$0.25	HK$0.25	HK$0.19	HK$0.19	HK$0.19	HK$0.18	HK$0.16	HK$0.13	HK$0.06	HK$0.11	HK$0.06	HK$0.06	HK$0.05	HK$0.01	HK$0.02	HK$0.01	HK$0.01	HK$0.00	HK$0.01	HK$0.01

Sino Biopharmaceutical financials at a glance

Financials

Discover